164 related articles for article (PubMed ID: 25843776)
1. The Bmi-1 helix-turn and ring finger domains are required for Bmi-1 antagonism of (-) epigallocatechin-3-gallate suppression of skin cancer cell survival.
Balasubramanian S; Scharadin TM; Han B; Xu W; Eckert RL
Cell Signal; 2015 Jul; 27(7):1336-44. PubMed ID: 25843776
[TBL] [Abstract][Full Text] [Related]
2. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
Balasubramanian S; Adhikary G; Eckert RL
Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.
Choudhury SR; Balasubramanian S; Chew YC; Han B; Marquez VE; Eckert RL
Carcinogenesis; 2011 Oct; 32(10):1525-32. PubMed ID: 21798853
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Nandakumar V; Vaid M; Katiyar SK
Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
[TBL] [Abstract][Full Text] [Related]
5. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
Bhatia N; Agarwal C; Agarwal R
Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
Nihal M; Ahmad N; Mukhtar H; Wood GS
Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting β-catenin signaling.
Singh T; Katiyar SK
Toxicol Appl Pharmacol; 2013 Dec; 273(2):418-24. PubMed ID: 24096034
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells.
Balasubramanian S; Chew YC; Eckert RL
Mol Pharmacol; 2011 Nov; 80(5):870-8. PubMed ID: 21807989
[TBL] [Abstract][Full Text] [Related]
10. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray.
Vittal R; Selvanayagam ZE; Sun Y; Hong J; Liu F; Chin KV; Yang CS
Mol Cancer Ther; 2004 Sep; 3(9):1091-9. PubMed ID: 15367703
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells.
Gupta S; Hussain T; Mukhtar H
Arch Biochem Biophys; 2003 Feb; 410(1):177-85. PubMed ID: 12559991
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
[TBL] [Abstract][Full Text] [Related]
14. The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.
Yang L; Zhang W; Chopra S; Kaur D; Wang H; Li M; Chen P; Zhang W
Curr Drug Targets; 2020; 21(11):1099-1104. PubMed ID: 32364072
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
Lim YC; Cha YY
J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
[TBL] [Abstract][Full Text] [Related]
16. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
17. Investigations of the cytotoxicity of epigallocatechin-3-gallate against PC-3 cells in the presence of Cd2+ in vitro.
Zhang LC; Yu HN; Sun SL; Yang JG; He GQ; Ruan H; Shen SR
Toxicol In Vitro; 2008 Jun; 22(4):953-60. PubMed ID: 18359184
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
Shankar S; Suthakar G; Srivastava RK
Front Biosci; 2007 Sep; 12():5039-51. PubMed ID: 17569628
[TBL] [Abstract][Full Text] [Related]
19. Anticlastogenic, antigenotoxic and apoptotic activity of epigallocatechin gallate: a green tea polyphenol.
Roy M; Chakrabarty S; Sinha D; Bhattacharya RK; Siddiqi M
Mutat Res; 2003; 523-524():33-41. PubMed ID: 12628501
[TBL] [Abstract][Full Text] [Related]
20. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
Fang MZ; Wang Y; Ai N; Hou Z; Sun Y; Lu H; Welsh W; Yang CS
Cancer Res; 2003 Nov; 63(22):7563-70. PubMed ID: 14633667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
